blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP1744160

EP1744160 - Use of adiponectin as marker in the prediction of post-operative infection [Right-click to bookmark this link]
Former [2007/03]METHOD OF INVASIVENESS CONTROL AND USE OF ADIPONECTIN
[2010/50]
StatusNo opposition filed within time limit
Status updated on  11.05.2012
Database last updated on 21.05.2024
Most recent event   Tooltip18.07.2014Lapse of the patent in a contracting state
New state(s): HU		published on 20.08.2014  [2014/34]
Applicant(s)For all designated states
Maeda, Kazuhisa
2-4-33, Hagoromo Takaishi-shi
Osaka 592-0002 / JP
For all designated states
Yamamoto, Hiroshi
1-5-6, Umebayashi Otsu-shi
Shiga 520-0051 / JP
[2011/22]
Former [2007/16]For all designated states
Maeda, Kazuhisa
2-4-33, Hagoromo Takaishi-shi
Osaka 592-0002 / JP
For all designated states
Yamamoto, Hiroshi
Kusatsu-shi
Shiga 525-0037 / JP
Former [2007/03]For all designated states
Maeda, Kazuhisa
2-4-33, Hagoromo Takaishi-shi
Osaka 592-0002 / JP
For all designated states
Yamamoto, Hiroshi
10-10-B705 Nishioojicho Kisatsu-shi
Shiga 5250037 / JP
Inventor(s)01 / see applicant
...
 [2007/03]
Representative(s)Hoffmann Eitle
Patent- und Rechtsanwälte PartmbB
Arabellastraße 30
81925 München / DE
[N/P]
Former [2008/31]HOFFMANN EITLE
Patent- und Rechtsanwälte Arabellastrasse 4
81925 München / DE
Former [2007/03]HOFFMANN EITLE
Patent- und Rechtsanwälte Arabellastrasse 4
81925 München / DE
Application number, filing date05727482.131.03.2005
[2007/03]
WO2005JP06395
Priority number, dateJP2004013482331.03.2004         Original published format: JP 2004134823
JP2004013482431.03.2004         Original published format: JP 2004134824
[2007/03]
Filing languageJA
Procedural languageEN
PublicationType: A2 Application without search report
No.:WO2005094188
Date:13.10.2005
Language:EN
[2005/41]
Type: A2 Application without search report 
No.:EP1744160
Date:17.01.2007
Language:EN
The application published by WIPO in one of the EPO official languages on 13.10.2005 takes the place of the publication of the European patent application.
[2007/03]
Type: B1 Patent specification 
No.:EP1744160
Date:06.07.2011
Language:EN
[2011/27]
Search report(s)International search report - published on:JP08.12.2005
(Supplementary) European search report - dispatched on:EP21.04.2008
ClassificationIPC:G01N33/53, G01N33/76
[2008/21]
CPC:
A61K38/2264 (EP,US); G01N33/53 (KR); G01N33/74 (US);
A61P31/00 (EP); A61P31/04 (EP); A61P43/00 (EP);
G01N33/48 (KR); G01N33/49 (KR) (-)
Former IPC [2007/03]G01N33/53
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   MC,   NL,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2007/03]
Extension statesALNot yet paid
BANot yet paid
HRNot yet paid
LVNot yet paid
MKNot yet paid
YUNot yet paid
TitleGerman:Verwendung von Adiponectin als Marker in der Vorhersage post-operativer Infektion[2010/50]
English:Use of adiponectin as marker in the prediction of post-operative infection[2010/50]
French:Utilisation de l'adiponectine comme marqueur pour la prédiction de l'infection post-opérative[2010/50]
Former [2007/03]VERFAHREN ZUR INVASIVITÄTSKONTROLLE UND VEWENDUNG VON ADIPONECTIN
Former [2007/03]METHOD OF INVASIVENESS CONTROL AND USE OF ADIPONECTIN
Former [2007/03]METHODE DE REGULATION DU POUVOIR ENVAHISSANT ET UTILISATION DE L'ADIPONECTINE
Entry into regional phase31.10.2006Translation filed 
31.10.2006National basic fee paid 
31.10.2006Search fee paid 
31.10.2006Designation fee(s) paid 
31.10.2006Examination fee paid 
Examination procedure31.10.2006Examination requested  [2007/03]
03.01.2007Amendment by applicant (claims and/or description)
19.08.2008Despatch of a communication from the examining division (Time limit: M04)
02.12.2008Reply to a communication from the examining division
25.05.2009Despatch of a communication from the examining division (Time limit: M04)
02.09.2009Reply to a communication from the examining division
10.11.2010Cancellation of oral proceeding that was planned for 01.12.2010
24.11.2010Communication of intention to grant the patent
01.12.2010Date of oral proceedings (cancelled)
22.03.2011Fee for grant paid
22.03.2011Fee for publishing/printing paid
Divisional application(s)EP10185392.7  / EP2279745
The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  19.08.2008
Opposition(s)11.04.2012No opposition filed within time limit [2012/24]
Fees paidRenewal fee
26.03.2007Renewal fee patent year 03
13.03.2008Renewal fee patent year 04
30.03.2009Renewal fee patent year 05
16.03.2010Renewal fee patent year 06
25.03.2011Renewal fee patent year 07
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU31.03.2005
AT06.07.2011
BE06.07.2011
CY06.07.2011
CZ06.07.2011
DK06.07.2011
EE06.07.2011
FI06.07.2011
LT06.07.2011
NL06.07.2011
PL06.07.2011
RO06.07.2011
SE06.07.2011
SI06.07.2011
SK06.07.2011
TR06.07.2011
BG06.10.2011
GR07.10.2011
IS06.11.2011
PT07.11.2011
CH31.03.2012
IE31.03.2012
IT31.03.2012
LI31.03.2012
LU31.03.2012
MC31.03.2012
ES01.04.2012
[2014/34]
Former [2014/27]AT06.07.2011
BE06.07.2011
CY06.07.2011
CZ06.07.2011
DK06.07.2011
EE06.07.2011
FI06.07.2011
LT06.07.2011
NL06.07.2011
PL06.07.2011
RO06.07.2011
SE06.07.2011
SI06.07.2011
SK06.07.2011
TR06.07.2011
BG06.10.2011
GR07.10.2011
IS06.11.2011
PT07.11.2011
CH31.03.2012
IE31.03.2012
IT31.03.2012
LI31.03.2012
LU31.03.2012
MC31.03.2012
ES01.04.2012
Former [2014/21]AT06.07.2011
BE06.07.2011
CY06.07.2011
CZ06.07.2011
DK06.07.2011
EE06.07.2011
FI06.07.2011
LT06.07.2011
NL06.07.2011
PL06.07.2011
RO06.07.2011
SE06.07.2011
SI06.07.2011
SK06.07.2011
TR06.07.2011
BG06.10.2011
GR07.10.2011
IS06.11.2011
PT07.11.2011
CH31.03.2012
IE31.03.2012
IT31.03.2012
LI31.03.2012
MC31.03.2012
ES01.04.2012
Former [2013/36]AT06.07.2011
BE06.07.2011
CY06.07.2011
CZ06.07.2011
DK06.07.2011
EE06.07.2011
FI06.07.2011
LT06.07.2011
NL06.07.2011
PL06.07.2011
RO06.07.2011
SE06.07.2011
SI06.07.2011
SK06.07.2011
BG06.10.2011
GR07.10.2011
IS06.11.2011
PT07.11.2011
CH31.03.2012
IE31.03.2012
IT31.03.2012
LI31.03.2012
MC31.03.2012
ES01.04.2012
Former [2013/29]AT06.07.2011
BE06.07.2011
CY06.07.2011
CZ06.07.2011
DK06.07.2011
EE06.07.2011
FI06.07.2011
LT06.07.2011
NL06.07.2011
PL06.07.2011
RO06.07.2011
SE06.07.2011
SI06.07.2011
SK06.07.2011
BG06.10.2011
GR07.10.2011
IS06.11.2011
PT07.11.2011
CH31.03.2012
IE31.03.2012
IT31.03.2012
LI31.03.2012
MC31.03.2012
Former [2013/11]AT06.07.2011
BE06.07.2011
CY06.07.2011
CZ06.07.2011
DK06.07.2011
EE06.07.2011
FI06.07.2011
LT06.07.2011
NL06.07.2011
PL06.07.2011
RO06.07.2011
SE06.07.2011
SI06.07.2011
SK06.07.2011
GR07.10.2011
IS06.11.2011
PT07.11.2011
CH31.03.2012
IE31.03.2012
IT31.03.2012
LI31.03.2012
MC31.03.2012
Former [2013/08]AT06.07.2011
BE06.07.2011
CY06.07.2011
CZ06.07.2011
DK06.07.2011
EE06.07.2011
FI06.07.2011
LT06.07.2011
NL06.07.2011
PL06.07.2011
RO06.07.2011
SE06.07.2011
SI06.07.2011
SK06.07.2011
GR07.10.2011
IS06.11.2011
PT07.11.2011
CH31.03.2012
IE31.03.2012
LI31.03.2012
MC31.03.2012
Former [2013/07]AT06.07.2011
BE06.07.2011
CY06.07.2011
CZ06.07.2011
DK06.07.2011
EE06.07.2011
FI06.07.2011
LT06.07.2011
NL06.07.2011
PL06.07.2011
RO06.07.2011
SE06.07.2011
SI06.07.2011
SK06.07.2011
GR07.10.2011
IS06.11.2011
PT07.11.2011
CH31.03.2012
LI31.03.2012
MC31.03.2012
Former [2012/47]AT06.07.2011
BE06.07.2011
CY06.07.2011
CZ06.07.2011
DK06.07.2011
EE06.07.2011
FI06.07.2011
LT06.07.2011
NL06.07.2011
PL06.07.2011
RO06.07.2011
SE06.07.2011
SI06.07.2011
SK06.07.2011
GR07.10.2011
IS06.11.2011
PT07.11.2011
MC31.03.2012
Former [2012/31]AT06.07.2011
BE06.07.2011
CY06.07.2011
CZ06.07.2011
DK06.07.2011
EE06.07.2011
FI06.07.2011
LT06.07.2011
NL06.07.2011
PL06.07.2011
RO06.07.2011
SE06.07.2011
SI06.07.2011
SK06.07.2011
GR07.10.2011
IS06.11.2011
PT07.11.2011
Former [2012/23]AT06.07.2011
BE06.07.2011
CY06.07.2011
CZ06.07.2011
EE06.07.2011
FI06.07.2011
LT06.07.2011
NL06.07.2011
PL06.07.2011
RO06.07.2011
SE06.07.2011
SI06.07.2011
SK06.07.2011
GR07.10.2011
IS06.11.2011
PT07.11.2011
Former [2012/21]AT06.07.2011
BE06.07.2011
CY06.07.2011
CZ06.07.2011
FI06.07.2011
LT06.07.2011
NL06.07.2011
PL06.07.2011
SE06.07.2011
SI06.07.2011
GR07.10.2011
IS06.11.2011
PT07.11.2011
Former [2012/12]AT06.07.2011
BE06.07.2011
CY06.07.2011
FI06.07.2011
LT06.07.2011
NL06.07.2011
PL06.07.2011
SE06.07.2011
SI06.07.2011
GR07.10.2011
IS06.11.2011
PT07.11.2011
Former [2012/11]AT06.07.2011
BE06.07.2011
FI06.07.2011
LT06.07.2011
NL06.07.2011
PL06.07.2011
SE06.07.2011
SI06.07.2011
GR07.10.2011
IS06.11.2011
PT07.11.2011
Former [2012/10]BE06.07.2011
FI06.07.2011
LT06.07.2011
NL06.07.2011
SE06.07.2011
SI06.07.2011
GR07.10.2011
IS06.11.2011
PT07.11.2011
Former [2012/09]BE06.07.2011
FI06.07.2011
LT06.07.2011
NL06.07.2011
SI06.07.2011
IS06.11.2011
PT07.11.2011
Former [2012/08]LT06.07.2011
NL06.07.2011
SI06.07.2011
IS06.11.2011
Former [2011/52]SI06.07.2011
Documents cited:Search[A]WO03016906  (REBIO GEN INC [JP], et al)[A] 1,3,6-8;
 [A]WO03062275  (PROTEMIX CORP LTD [NZ], et al) [A] 1,3,6-8 * claims 134,138,197,201 *;
 [A]WO2004022596  (KOMED CO LTD [KR], et al) [A] 1,6-8 * page 2, paragraph 4 - page 3, paragraphs 1,4,5 * * claim 13 *;
 [PA]EP1426764  (REBIO GEN INC [JP]) [PA] 1,3,6-8 * paragraph [0011] * * claim 1 *;
 [A]  - KELLER P ET AL, "Circulating adiponectin levels during human endotoxaemia.", CLINICAL AND EXPERIMENTAL IMMUNOLOGY, (200310), vol. 134, no. 1, ISSN 0009-9104, pages 107 - 110, XP008089950 [A] 1,5,6 * page 107, column 1, paragraph 2 * * page 108, column 1, paragraph 1 - paragraph 3 * * page 108, column 1, paragraph 4 - page 109, column 2, paragraph 5 *

DOI:   http://dx.doi.org/10.1046/j.1365-2249.2003.02264.x
 [A]  - GIUGLIANO G ET AL, "Effect of liposuction on insulin resistance and vascular inflammatory markers in obese women.", BRITISH JOURNAL OF PLASTIC SURGERY APR 2004, vol. 57, no. 3, ISSN 0007-1226, (20040218), pages 1 - 7, URL: http://www.sciencedirect.com/science?_ob=ArticleURL&_udi=B6WC6-4BRB6N1-3&_user=987766&_coverDate=04%2F30%2F2004&_alid=720326058&_rdoc=1&_fmt=full&_orig=search&_cdi=6730&_sort=d&_st=0&_docanchor=&_ct=1&_acct=C000049880&_version=1&_urlVersion=0&_userid=987766&md5=d60275cf28b36917fc762553cc218ca8, (20080401), XP002475617 [A] 1,3 * the whole document *

DOI:   http://dx.doi.org/10.1016/j.bjps.2003.12.010
 [A]  - TANOWITZ H B ET AL, "Role of the adipocyte in Trypanosoma cruzi infection.", AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, & 52ND ANNUAL MEETING OF THE AMERICAN SOCIETY OF TROPICAL MEDICINE AND HYGIENE; PHILADELPHIA, PA, USA; DECEMBER 03-07, 2003, (200309), vol. 69, no. 3 Supplement, ISSN 0002-9637, page 289, XP008089929 [A] 1 * abstract *
 [T]  - TSUCHIHASHI ET AL, "Circulating Concentrations of Adiponectin, an Endogenous Lipopolysaccharide Neutralizing Protein, Decrease in Rats with Polymicrobial Sepsis", JOURNAL OF SURGICAL RESEARCH, ACADEMIC PRESS INC., SAN DIEGO, CA, US, (200608), vol. 134, no. 2, ISSN 0022-4804, pages 348 - 353, XP005569436 [T] 1-16 * the whole document *
International search[X]JPH0318186B  ;
 [X]WO03016906  (REBIO GEN INC [JP], et al);
 [X]  - YOKOTA T. ET AL., "Shibo Saibo o Sansei suru adiponectin to Macrophage Kino.", CLINICAL IMMUNOLOGY, (2000), vol. 34, no. 5, pages 584 - 590, XP002997651
by applicant   - KELLER P; MOLLER K; KRABBE KS; PEDERSEN BK, "Circulating adiponectin levels during human endotoxaemia", CLIN. EXP. IMMUNOL., (2003), vol. 134, pages 107 - 110
    - TANOWITZ HB; MUKHERJEE S; ZHAO D; BRAUNSTEIN VB; COMBS TP; SCHERER P, AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, (2003), vol. 69, no. 3, page 289
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.